| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 430 | $90 | $37.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 240 | $140 | $32K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 260 | $60 | $15.4K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 130 | $110 | $13.5K |
| 52000 | In this procedure, the provider performs an examination of the interior of the bladder, the urethra, and the ureteric openings by means of a cystourethroscope, a thin flexible or rigid tube with a… | 100 | $60 | $6.1K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 90 | $70 | $5.9K |
| 52353 | The provider performs a cystourethroscopy, the inspection of the interior of the bladder, the urethra, prostatic urethra, and ureteric openings using a cystoscope passed through the urethra and into… | 20 | $290 | $4.7K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 430 | $10 | $3K |
| J9030 | BCG live intravesical instillation, 1 mg | 1,480 | $1 | $3K |
| 52235 | The provider inspects the urethra, prostatic urethra (in men), the interior of the bladder, and ureteric openings using a cystoscope passed through the urethra and into the bladder; he destroys… | 10 | $210 | $2.7K |